Introduction
Materials and methods
Search strategy and study selection
Data extraction and outcome measures
Quality assessment in individual studies
Statistical analysis
Quality of evidence
Results
Literature search, study characteristics and quality assessment
NO | Author | ESPB group | PVB group | Operation | Analgesic medication | Outcomes | Jada scores | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number | Age (years) | Male (n) | Body mass index (kg/m2) | ASA (I/II) | Methods | Number | Age (years) | Male (n) | Body mass index (kg/m2) | ASA (I/II) | Methods | ||||||
1 | Zhang 2022 | 22 | 54.41 ± 7.61 | 11 | 25.56 ± 3.01 | 7/15 | ESPB with 30 ml of 0.5% ropivacaine hydrochloride | 22 | 54.32 ± 6.56 | 10 | 25.47 ± 2.65 | 9/13 | PVB with 30 ml of 0.5% ropivacaine hydrochloride | Elective thoracoscopic pulmonary lobectomy | 0.05 mg/kg of midazolam, 0.5 μg/kg of sufentanil, 0.6 mg/kg of rocuronium, and 0.3 mg/kg of etomidate Were given sequentially by intravenous infusion | Pain scores at 1–2 h, 4–6 h and 12 h, postoperative analgesic consumption, nausea and vomiting | 4 |
2 | Fu 2022 | 20 | 57.25 ± 11.25 | 14 | 23.4 ± 2.46 | 12/8 | ESPB with 20 ml of 0.5% ropivacaine | 22 | 58.63 ± 6.04 | 8 | 23.79 ± 2.78 | 14/8 | PVB with 20 ml of 0.5% ropivacaine | Video-assisted thoracoscopic surgery | Propofol 2.0 mg/kg, sufentanil 0.4 µg/kg and cis‑atracurium 0.2 mg/kg | Postoperative analgesic consumption, nausea and vomiting | 4 |
3 | Turhan 2021 | 35 | 53.31 ± 9.03 | 19 | 24.38 ± 1.57 | 13/19 | ESPB with 20 mL of 0.5% bupivacaine | 35 | 53.97 ± 7.34 | 16 | 23.78 ± 2.04 | 13/18 | PVB with 20 mL of 0.5% bupivacaine | Thoracoscopic lung surgery | Propofol (2 mg/kg), fentanyl (3 mcg/kg) and rocuronium (0.5 mg/kg) | Pain scores at 1–2 h, 4–6 h and 12 h, postoperative analgesic consumption | 4 |
4 | Zhao 2020 | 33 | 59 ± 5 | 18 | – | 11/21 | ESPB with 15 mL of 0.4% ropivacaine | 33 | 57 ± 6 | 11 | – | 9/24 | PVB with 15 mL of 0.4% ropivacaine | Video-assisted thoracic surgery | Etomidate (0.1 mg/kg), propofol (1 mg/kg), sufentanil (0.3 μg/kg) and cis-atracuronium (0.15 mg/kg) | Postoperative analgesic consumption | 4 |
5 | Çiftçi 2020 | 30 | 47.33 ± 10.21 | 15 | – | 16/14 | ESPB with 20 mL of 0.25% bupivacaine | 30 | 47.53 ± 10.43 | 15 | – | 11/19 | PVB with 20 mL of 0.25% bupivacaine | Video assisted thoracic surgery | Propofol (2–2.5 mg/kg), fentanyl (1–1.5 µg/kg), and rocuronium bromide (0.6 mg/kg) | Postoperative analgesic consumption, nausea and vomiting | 5 |
6 | Chen 2020 | 24 | 51.6 ± 10.4 | 13 | 22.9 ± 2.6 | 9/15 | ESPB with 6.7 ml of 0.375% ropivacaine | 24 | 58.1 ± 7.0 | 15 | 23.5 ± 2.4 | 9/15 | PVB with 7 ml of 0.375% ropivacaine | Elective thoracoscopic partial pulmonary resection surgery | Sufentanil 0.5 μg/kg, propofol 1.5–2.0 mg/kg and rocuronium 0.8 mg/kg | Postoperative analgesic consumption | 5 |
7 | Taketa 2019 | 41 | 70 ± 7 | 23 | 23.6 ± 3.4 | 2/29 | ESPB with 20 mL of 0.2% levobupivacaine | 40 | 67 ± 8 | 25 | 23.4 ± 3.2 | 2/29 | PVB with 20 mL of 0.2% levobupivacaine | Video- assisted thoracic surgery | Fentanyl (50 µg), remifentanil (0.2–0.5 µg/kg/min) and rocuronium (0.6–1 mg/kg) | Pain scores at 1–2 h, 4–6 h and 12 h, nausea and vomiting | 4 |